Provided by Tiger Fintech (Singapore) Pte. Ltd.

MAIA Biotechnology Inc.

1.94
-0.1250-6.07%
Volume:201.69K
Turnover:409.98K
Market Cap:57.25M
PE:-1.85
High:2.17
Open:2.15
Low:1.90
Close:2.06
Loading ...

MAIA Biotechnology Shares Rise After Supply Agreement With BeiGene

Dow Jones
·
08 Jan

MAIA Biotechnology enters clinical supply agreement with BeiGene for THIO

TIPRANKS
·
07 Jan

Maia Biotechnology: Under Deal, Maia to Sponsor, Fund Planned Clinical Trials & Beigene Will Provide Tislelizumab

THOMSON REUTERS
·
07 Jan

Maia Biotechnology Announces Clinical Supply Agreement With Beigene for Upcoming Phase 2 Trials in Three Cancer Indications

THOMSON REUTERS
·
07 Jan

MAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer Indications

Business Wire
·
07 Jan

BRIEF-MAIA Biotechnology Increased Maximum Offering Price Of Shares Of Common Stock Issuable Under At Market Offering Agreement To $30 Million

Reuters
·
24 Dec 2024

Maia Biotechnology : Increased Maximum Offering Price of Shares of Common Stock Issuable Under at Market Offering Agreement to $30 Mln

THOMSON REUTERS
·
24 Dec 2024

Maia Biotechnology Announces Director Participation in Recent Private Placement Closings

THOMSON REUTERS
·
19 Dec 2024

MAIA Biotechnology Announces Director Participation in Recent Private Placement Closings

Business Wire
·
19 Dec 2024

Sector Update: Health Care Stocks Slide Late Afternoon

MT Newswires Live
·
17 Dec 2024

Sector Update: Health Care Stocks Decline Monday Afternoon

MT Newswires Live
·
17 Dec 2024

MAIA Biotechnology granted FDA rare pediatric disease designation for THIO

TIPRANKS
·
17 Dec 2024

MAIA Biotechnology's THIO Gets US FDA Rare Pediatric Disease Designation to Treat Pediatric High-Grade Gliomas

MT Newswires Live
·
16 Dec 2024

Maia Biotechnology Granted FDA Rare Pediatric Disease Designation for Thio as a Treatment for Pediatric High-Grade Gliomas

THOMSON REUTERS
·
16 Dec 2024

MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas

Business Wire
·
16 Dec 2024

MAIA Biotechnology to sell 507,364 shares at $1.872 in private placement

TIPRANKS
·
10 Dec 2024

Maia Biotechnology Announces Private Placement of Approximately $950,000

THOMSON REUTERS
·
10 Dec 2024

MAIA Biotechnology Announces Private Placement of Approximately $950,000

Business Wire
·
10 Dec 2024

Amazon Bedrock Empowers Customers to Accelerate Generative AI Adoption with More Than 100 New Models and Powerful New Capabilities for Inference and Working with Data

Business Wire
·
05 Dec 2024

Maia Biotechnology, Regeneron Expand Clinical Supply Deal

MT Newswires Live
·
03 Dec 2024